Essential (Primary) Hypertension
6
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive Patients
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
Smartphone-Guided Paced Breathing and Aerobic Exercise for Essential Hypertension
Evaluating the Effects of a Mindfulness Intervention on Health Outcomes in Individuals With Hypertension
Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure
Positive Care Effect of the Digital Health Assistant ADELE Blood Pressure for Hypertension Patients